Andrew Tolve
Andrew Tolve
Latest posts from :
Andrew Tolve explores how medication possession ratios (MPRs) and tailored ...
Lucas Merrow, CEO of Eliza Corporation, details the effect of multi-touch ...
Results from an eyeforpharma survey suggest there is little consensus about ...
Leandro Herrero, CEO of consulting firm The Chalfont Project, on how the ...
Joseph DeFeo, product director at IntegriChain, on how tracking retail ...
Chris Morgan, a principal at ZS Associates, explains the keys to successful ...
Huw Tippett, head of global sales for Novartis, explains his firm's new...
Andrew Tolve reports on the likely impact of US healthcare reforms on the ...